{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T03:22:16Z","timestamp":1768620136282,"version":"3.49.0"},"reference-count":66,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.3892\/mmr.2015.3770","type":"journal-article","created":{"date-parts":[[2015,5,12]],"date-time":"2015-05-12T07:48:17Z","timestamp":1431416897000},"page":"3073-3080","source":"Crossref","is-referenced-by-count":21,"title":["Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice"],"prefix":"10.3892","volume":"12","author":[{"given":"WU","family":"LI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MIN","family":"LI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GUANGCUN","family":"DENG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LIPING","family":"ZHAO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XIAOMING","family":"LIU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YUJIONG","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,5,12]]},"reference":[{"key":"key20180108022123_b1-mmr-12-02-3073","first-page":"306","volume-title":"Global Tuberculosis Report 2012","author":"World Health Organization (WHO)","year":"2012"},{"key":"key20180108022123_b2-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"339","DOI":"10.7196\/SAMJ.8290","article-title":"Tuberculosis preventive therapy: An underutilised strategy to reduce individual risk of TB and contribute to TB control","volume":"104","author":"Churchyard","year":"2014","journal-title":"S Afr Med J"},{"key":"key20180108022123_b3-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"e64745","DOI":"10.1371\/journal.pone.0064745","article-title":"Molecular epidemiology, drug susceptibility and economic aspects of tuberculosis in Mubende district, Uganda","volume":"8","author":"Muwonge","year":"2013","journal-title":"PLoS One"},{"key":"key20180108022123_b4-mmr-12-02-3073","first-page":"455","article-title":"Effectiveness of BCG vaccination against tuberculous meningitis","volume":"36","author":"Awasthi","year":"1999","journal-title":"Indian Pediatr"},{"key":"key20180108022123_b5-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1016\/j.ijid.2008.06.014","article-title":"Bacillus Calmette-Gu\u00e9rin (BCG) vaccine-induced complications in children treated with highly active antiretroviral therapy","volume":"12","author":"Nuttall","year":"2008","journal-title":"Int J Infect Dis"},{"key":"key20180108022123_b6-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/adc.2005.078972","article-title":"Complications associated with the bacille Calmette-Gu\u00e9rin vaccination in Ireland","volume":"91","author":"Bolger","year":"2006","journal-title":"Arch Dis Child"},{"key":"key20180108022123_b7-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.micinf.2005.03.009","article-title":"Prime-boost immunisation strategies for tuberculosis","volume":"7","author":"McShane","year":"2005","journal-title":"Microbes Infect"},{"key":"key20180108022123_b8-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.vaccine.2013.11.045","article-title":"Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-priming and boosting with adenovirus or protein based vaccines","volume":"32","author":"Dean","year":"2014","journal-title":"Vaccine"},{"key":"key20180108022123_b9-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1016\/j.vaccine.2012.01.048","article-title":"A recombinant adenovirus expressing immunodominant TB antigens can significantly enhance BCG-induced human immunity","volume":"30","author":"Hoft","year":"2012","journal-title":"Vaccine"},{"key":"key20180108022123_b10-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1128\/CVI.00275-12","article-title":"Goats primed with Mycobacterium bovis BCG and boosted with a recombinant adenovirus expressing Ag85A show enhanced protection against tuberculosis","volume":"19","author":"Perez de Val","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"key20180108022123_b11-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1744-313X.2011.01066.x","article-title":"Protection against Mycobacterium tuberculosis challenge in mice by DNA vaccine Ag85A-ESAT-6-IL-21 priming and BCG boosting","volume":"39","author":"Dou","year":"2012","journal-title":"Int J Immunogenet"},{"key":"key20180108022123_b12-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.vaccine.2012.11.042","article-title":"Prime-boost BCG vaccination with DNA vaccines based in \u03b2-defensin-2 and mycobacterial antigens ESAT6 or Ag85B improve protection in a tuberculosis experimental model","volume":"31","author":"Cervantes-Villagrana","year":"2013","journal-title":"Vaccine"},{"key":"key20180108022123_b13-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tube.2006.01.017","article-title":"Use of recombinant virus-vectored tuberculosis vaccines for respiratory mucosal immunization","volume":"86","author":"Xing","year":"2006","journal-title":"Tuberculosis"},{"key":"key20180108022123_b14-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/mt.2009.130","article-title":"New insights on adenovirus as vaccine vectors","volume":"17","author":"Lasaro","year":"2009","journal-title":"Mol Ther"},{"key":"key20180108022123_b15-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"6357","DOI":"10.4049\/jimmunol.173.10.6357","article-title":"Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis","volume":"173","author":"Wang","year":"2004","journal-title":"J Immunol"},{"key":"key20180108022123_b16-mmr-12-02-3073","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/791728","article-title":"Roles of mucosal immunity against Mycobacterium tuberculosis infection","author":"Li","year":"2012","journal-title":"Tuberc Res Treat"},{"key":"key20180108022123_b17-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1016\/S0264-410X(00)00481-3","article-title":"Vaccines and mucosal immunisation","volume":"19","author":"Cripps","year":"2001","journal-title":"Vaccine"},{"key":"key20180108022123_b18-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.molimm.2014.06.007","article-title":"A recombinant adenovirus expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis elicits strong antigen-specific immune responses in mice","volume":"62","author":"Li","year":"2014","journal-title":"Mol Immunol"},{"key":"key20180108022123_b19-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1365-3083.2010.02448.x","article-title":"Recombinant Mycobacterium smegmatis expressing an ESAT6-CFP10 fusion protein induces anti-mycobacterial immune responses and protects against Mycobacterium tuberculosis challenge in mice","volume":"72","author":"Zhang","year":"2010","journal-title":"Scand J Immunol"},{"key":"key20180108022123_b20-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/1574-695X.12008","article-title":"Immunogenicity and therapeutic effects of Ag85A\/B chimeric DNA vaccine in mice infected with Mycobacterium tuberculosis","volume":"66","author":"Liang","year":"2012","journal-title":"FEMS Immunol Med Microbiol"},{"key":"key20180108022123_b21-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tube.2010.12.003","article-title":"Vaccine for tuberculosis: up-regulation of IL-15 by Ag85A and not by ESAT-6","volume":"91","author":"Pydi","year":"2011","journal-title":"Tuberculosis (Edinb)"},{"key":"key20180108022123_b22-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/1574-6968.12525","article-title":"Recombinant Bacillus subtilis spores expressing MPT64 evaluated as a vaccine against tuberculosis in the murine model","volume":"358","author":"Sibley","year":"2014","journal-title":"FEMS Microbiol Lett"},{"key":"key20180108022123_b23-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s11095-009-9995-y","article-title":"Rational design of multiple TB antigens TB10.4 and TB10.4-Ag85B as subunit vaccine candidates against Mycobacterium tuberculosis","volume":"27","author":"Shi","year":"2010","journal-title":"Pharm Res"},{"issue":"Pt 11","key":"key20180108022123_b24-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1099\/00221287-144-11-3195","article-title":"A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10)","volume":"144","author":"Berthet","year":"1998","journal-title":"Microbiology"},{"key":"key20180108022123_b25-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1046\/j.1365-2958.1999.01383.x","article-title":"Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays","volume":"32","author":"Gordon","year":"1999","journal-title":"Mol Microbiol"},{"key":"key20180108022123_b26-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1126\/science.284.5419.1520","article-title":"Comparative genomics of BCG vaccines by whole-genome DNA microarray","volume":"284","author":"Behr","year":"1999","journal-title":"Science"},{"key":"key20180108022123_b27-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1086\/345862","article-title":"Deletion of RD1 from Mycobacterium tuberculosis mimics Bacille Calmette-Guerin attenuation","volume":"187","author":"Lewis","year":"2003","journal-title":"J Infect Dis"},{"key":"key20180108022123_b28-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1046\/j.1365-2958.2002.03237.x","article-title":"Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti","volume":"46","author":"Pym","year":"2002","journal-title":"Mol Microbiol"},{"key":"key20180108022123_b29-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3109\/08820139.2012.658940","article-title":"Immune responses induced by heterologous boosting of recombinant bacillus Calmette-Guerin with Ag85B-ESAT6 fusion protein in levamisole-based adjuvant","volume":"41","author":"You","year":"2012","journal-title":"Immunol Invest"},{"key":"key20180108022123_b30-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1016\/j.vaccine.2011.06.029","article-title":"Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice","volume":"30","author":"Yuan","year":"2012","journal-title":"Vaccine"},{"key":"key20180108022123_b31-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-3083.2011.02655.x","article-title":"Recombinant adenovirus delivery of calreticulin-ESAT-6 produces an antigen-specific immune response but no protection against a Mycobacterium tuberculosis challenge","volume":"75","author":"Esparza-Gonz\u00e1lez","year":"2012","journal-title":"Scand J Immunol"},{"key":"key20180108022123_b32-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1600-0463.2011.02815.x","article-title":"Recombinant BCG coexpressing Ag85B, CFP10 and interleukin-12 induces multifunctional Th1 and memory T cells in mice","volume":"120","author":"Lin","year":"2012","journal-title":"APMIS"},{"key":"key20180108022123_b33-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"e50447","DOI":"10.1371\/journal.pone.0050447","article-title":"Optimising immunoge-nicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection","volume":"7","author":"Betts","year":"2012","journal-title":"PLoS One"},{"key":"key20180108022123_b34-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.4049\/jimmunol.177.9.6353","article-title":"Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette-Guerin immunity","volume":"177","author":"Dietrich","year":"2006","journal-title":"J Immunol"},{"key":"key20180108022123_b35-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.imbio.2009.04.002","article-title":"Investigation of immunogenic effect of the BCG priming and Ag85A-GM-CSF boosting in Balb\/c mice model","volume":"215","author":"Dou","year":"2010","journal-title":"Immunobiology"},{"key":"key20180108022123_b36-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1208\/s12248-010-9193-1","article-title":"Pulmonary immunization using antigen 85-B polymeric microparticles to boost tuberculosis immunity","volume":"12","author":"Lu","year":"2010","journal-title":"AAPS J"},{"key":"key20180108022123_b37-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"6101","DOI":"10.4049\/jimmunol.160.12.6101","article-title":"Lack of both types 1 and 2 cytokines, tissue inflammatory responses and immune protection during pulmonary infection by Mycobacterium bovis bacille Calmette-Guerin in IL-12-deficient mice","volume":"160","author":"Wakeham","year":"1998","journal-title":"J Immunol"},{"key":"key20180108022123_b38-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1365-2567.2004.01809.x","article-title":"Passive protection with immunoglobulin A antibodies against tuberculous early infection of the lungs","volume":"111","author":"Williams","year":"2004","journal-title":"Immunology"},{"issue":"Suppl 1","key":"key20180108022123_b39-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2172-14-S1-S13","article-title":"Evaluation of the humoral immune response and cross reactivity against Mycobacterium tuberculosis of mice immunized with liposomes containing glycolipids of Mycobacterium smegmatis","volume":"14","author":"Borrero","year":"2013","journal-title":"BMC Immunol"},{"key":"key20180108022123_b40-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0140-6736(05)67145-0","article-title":"Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial","volume":"366","author":"Rodrigues","year":"2005","journal-title":"Lancet"},{"key":"key20180108022123_b41-mmr-12-02-3073","first-page":"536","article-title":"A case-control study of protection against tuberculosis by BCG revaccination in Recife, Brazil","volume":"10","author":"Dantas","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"key20180108022123_b42-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.vaccine.2005.07.103","article-title":"Decreased survival of guinea pigs infected with Mycobacterium tuberculosis after multiple BCG vaccinations","volume":"24","author":"Basaraba","year":"2006","journal-title":"Vaccine"},{"key":"key20180108022123_b43-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"6411","DOI":"10.1128\/IAI.71.11.6411-6419.2003","article-title":"Revaccination of neonatal calves with Mycobacterium bovis BCG reduces the level of protection against bovine tuberculosis induced by a single vaccination","volume":"71","author":"Buddle","year":"2003","journal-title":"Infect Immun"},{"key":"key20180108022123_b44-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/35021239","article-title":"Vaccines against intracellular infections requiring cellular immunity","volume":"406","author":"Seder","year":"2000","journal-title":"Nature"},{"key":"key20180108022123_b45-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.immunol.19.1.93","article-title":"Immunology of tuberculosis","volume":"19","author":"Flynn","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"key20180108022123_b46-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"8595","DOI":"10.4049\/jimmunol.181.12.8595","article-title":"Mycobacterium tuberculosis-specific CD8+T cells require perforin to kill target cells and provide protection in vivo","volume":"181","author":"Woodworth","year":"2008","journal-title":"J Immunol"},{"key":"key20180108022123_b47-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1126\/science.1065543","article-title":"Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells","volume":"295","author":"Szabo","year":"2002","journal-title":"Science"},{"key":"key20180108022123_b48-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/sj.icb.7100037","article-title":"Pulmonary epithelial cells are a source of interferon-\u03b3 in response to Mycobacterium tuberculosis infection","volume":"85","author":"Sharma","year":"2007","journal-title":"Immunol Cell Biol"},{"key":"key20180108022123_b49-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.4049\/jimmunol.162.6.3504","article-title":"Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuber- culosis infection, which is not compensated for by lymphotoxin","volume":"162","author":"Bean","year":"1999","journal-title":"J Immunol"},{"key":"key20180108022123_b50-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/0167-5699(93)90245-G","article-title":"A three-tiered view of the role of IgA in mucosal defense","volume":"14","author":"Mazanec","year":"1993","journal-title":"Immunol Today"},{"key":"key20180108022123_b51-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1126\/science.177.4050.697","article-title":"Inhibition of bacterial adherence by secretory immunoglobulin A: a mechanism of antigen disposal","volume":"177","author":"Williams","year":"1972","journal-title":"Science"},{"key":"key20180108022123_b52-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/intimm\/dxl017","article-title":"Polymeric IgR knockout mice are more susceptible to mycobacterial infections in the respiratory tract than wild-type mice","volume":"18","author":"Tj\u00e4rnlund","year":"2006","journal-title":"Int Immunol"},{"key":"key20180108022123_b53-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/2049-632X.12069","article-title":"The protective effect of immunoglobulin in murine tuberculosis is dependent on IgG glycosylation","volume":"69","author":"Olivares","year":"2013","journal-title":"Pathog Dis"},{"key":"key20180108022123_b54-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","article-title":"TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties","volume":"7","author":"Mosmann","year":"1989","journal-title":"Annu Rev Immunol"},{"key":"key20180108022123_b55-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"6711","DOI":"10.1016\/j.vaccine.2014.08.089","article-title":"The mucosal immune system for vaccine development","volume":"32","author":"Lamichhane","year":"2014","journal-title":"Vaccine"},{"key":"key20180108022123_b56-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.171.3.1602","article-title":"Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Gu\u00e9rin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara","volume":"171","author":"Goonetilleke","year":"2003","journal-title":"J Immunol"},{"key":"key20180108022123_b57-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1128\/IAI.72.1.238-246.2004","article-title":"Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis","volume":"72","author":"Chen","year":"2004","journal-title":"Infect Immun"},{"key":"key20180108022123_b58-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1128\/IAI.00517-06","article-title":"Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis","volume":"74","author":"Santosuosso","year":"2006","journal-title":"Infect Immun"},{"key":"key20180108022123_b59-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.nano.2012.02.015","article-title":"Nanoparticle-based adjuvant for enhanced protective efficacy of DNA vaccine Ag85A-ESAT-6-IL-21 against Mycobacterium tuberculosis infection","volume":"8","author":"Yu","year":"2012","journal-title":"Nanomedicine"},{"key":"key20180108022123_b60-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S2213-2600(15)00037-5","article-title":"Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: A randomised, placebo-controlled, phase 2 trial","volume":"3","author":"Ndiaye","year":"2015","journal-title":"Lancet Respir Med"},{"key":"key20180108022123_b61-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"e3548","DOI":"10.1371\/journal.pone.0003548","article-title":"Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice","volume":"3","author":"Croyle","year":"2008","journal-title":"PLoS One"},{"key":"key20180108022123_b62-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"10078","DOI":"10.1128\/JVI.77.18.10078-10087.2003","article-title":"Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system","volume":"77","author":"Lemiale","year":"2003","journal-title":"J Virol"},{"issue":"Suppl 3","key":"key20180108022123_b63-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1093\/infdis\/jir332","article-title":"Impact of systemic or mucosal immunity to adenovirus on Ad-based Ebola virus vaccine efficacy in guinea pigs","volume":"204","author":"Richardson","year":"2011","journal-title":"J Infect Dis"},{"key":"key20180108022123_b64-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"7986","DOI":"10.4049\/jimmunol.174.12.7986","article-title":"Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen","volume":"174","author":"Santosuosso","year":"2005","journal-title":"J Immunol"},{"key":"key20180108022123_b65-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/1743-422X-9-215","article-title":"Sublingual immunization with recombinant adenovirus encoding SARS-CoV spike protein induces systemic and mucosal immunity without redirection of the virus to the brain","volume":"9","author":"Shim","year":"2012","journal-title":"Virol J"},{"key":"key20180108022123_b66-mmr-12-02-3073","doi-asserted-by":"crossref","first-page":"5986","DOI":"10.1128\/JVI.02563-09","article-title":"Route of adenovirus-based HIV-1 vaccine delivery impacts the phenotype and trafficking of vaccine-elicited CD8+ T lymphocytes","volume":"84","author":"Kaufman","year":"2010","journal-title":"J Virol"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2015.3770\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T11:58:35Z","timestamp":1691668715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2015.3770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,12]]},"references-count":66,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,5,12]]},"published-print":{"date-parts":[[2015,8]]}},"alternative-id":["10.3892\/mmr.2015.3770"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2015.3770","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,12]]}}}